IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Tyndall Capital Partners L P

Q2 2019 Holdings

Filed 2019-08-14 | 3 holdings | $4.9K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
MMA Capital Holdings Inc(MMAC)COM55315D105$2.5K75,65251.5%
Onconova Therapeutics IncCOM NEW68232V405$2.3K813,43447.1%
Onconova Therapeutics Inc*W EXP 07/07/20268232V116$70390,6241.4%